Đang chuẩn bị liên kết để tải về tài liệu:
Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

Due to tumor heterogeneity, the diagnosis, treatment, and prognosis of patients with lung squamous cell carcinoma (LUSC) are difficult. DNA methylation is an important regulator of gene expression, which may help the diagnosis and therapy of patients with LUSC. |

TÀI LIỆU LIÊN QUAN

Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: A population-based cohort study

Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling

External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations

Expression of matrix metalloproteinases and their inhibitors in different immunohistochemical-based molecular subtypes of breast cancer

Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma

Impact of molecular subtypes on the prediction of distant recurrence in estrogen receptor (ER) positive, human epidermal growth factor receptor 2 (HER2) negative breast cancer upon five years of endocrine therapy

Gene expression profiles in genome instability-based classes of colorectal cancer

Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment

Deep learning identified glioblastoma subtypes based on internal genomic expression ranks